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Summary
The cytotoxic activity and pore-forming protein (PFP) expression of human peripheral blood
(PB) y/S T cellswere examined. Fresh y/S T cellsisolated from PB lymphocytes by fluorescence-
activated cell sorting exhibited a substantial natural killer-like cytotoxic activity against K562
target cells and had a high cytotoxic potential triggered by anti-CD3 monoclonal antibody (mAb)
against P815 target cells bearing FcyR. Immunocytochemical staining with an anti-PFP mAb
revealed that virtually all PB y/S T cells are granular lymphocytes with abundant PFP in their
cytoplasmic granules. Constitutive expression of PFP in PB 'y/6 T cells was also demonstrated
by Northern blot analysis. These observations support the proposed role ofy/S T cells in cytolysic
immune surveillance in vivo.
H
uman peripheral blood (PB) contains T cells bearing
two different sets of TCR chains: a/0 and y/6 (1).
In contrast to the well-characterized regulatory and effector
functions of a/f3 T cells, those of y/S T cells are largely
unknown.
The y/S T cell lines maintained in conditioned medium
containing IIr2 generally exhibit MHC-unrestricted cytotox-
icity not only against NK-susceptible target cells but also
against NK-resistant target cells (lymphokine-activated killer
[LAK] cytotoxicity) (1). In conjunction with the recent dis-
covery that some y/S T cells react with bacterial antigens
and heat-shockproteins (2), it was proposed that y/S T cells
may play a role in cytolysic immune surveillance for infected
or transformed cells (3). However, cytolysic function of fresh
y/S T cells remains to be determined.
We describe here that PB y/S T cells have a high cytolysic
potential without Ih2 stimulation, and constitutively express
pore-forming protein (PFP), which is a potent mediator of
cell-mediated cytolysis (4).
Materials and Methods
mAbs.
￿
Unlabeled anti-Leu-4 (anti-CD3) mAb and hybridoma
cells producing 3G8 (anti-CD16) mAb were provided by Dr. L.L.
Lanier (Becton Dickinson Immunocytometry Systems, Mountain
View, CA) and Dr. J.C. Unkeless (Mount Sinai Medical School,
New York), respectively. The hybridoma cells producing OKT4
mAb and OKT8 mAb were obtained from the American Type Cul-
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ture Collection (Rockville, MD). FITC- or PE-conjugated anti-
Leu-2a (anti-CD8), anti-Leu-4, and anti-Leu-19 (anti-CD56) mAbs
were purchased from Becton Dickinson ImmunocytometrySystems.
FITC-conjugated TCRS-1(antiTCR-y/S) was purchased from T
Cell Sciences (Cambridge, MA).
CellPreparation andCulture
￿
PBMC were isolated from the blood
of healthy donors using Ficoll-Hypaque. After depleting mono-
cytes and B cells by adherence to plastic dishes and nylon wool,
highly enriched populations of CD3' T cells (whole T cells) and
CD3 -56' large granular lymphocytes (LGL) were obtained by dis-
continuous Percoll density gradient centrifugation as described pre-
viously (5). CD8 4 TCR-,y/6- T cells (>95%) and TCRy/6'
T cells (>95%) were isolated from the whole T cells by sorting
on a FACStar (Becton Dickinson & Co.). CD3 -56' NK cells
(>95%) were sorted from the LGL population. Thymocytes were
obtained from children (< 5 yr old) undergoing correctivecardiac
surgery. TCR-y/S' thymocytes were sorted from CD4-8 - thymo-
cytes prepared by treatment with OKT4 mAb, OKT8 mAb, and
C. Isolated NK and T cell subsets (1-2 x 1( 6/ml) were stimu-
lated with 100-1,000 U/ml of human rID2 (generously supplied
by Shionogi Pharm. Co. Ltd., Osaka, Japan, and Cetus Corp.,
Emeryville, CA) for 6-18 h as previously described (5).
Cytotoxicity Assay.
￿
Cytotoxicity was measured in a standard
4-h "Cr release assay (5). In all experiments, graded numbers of
effector cells were added to 5 x 103 "Cr-labeled target cells. Lytic
units (LU) were defined as the number of effector cells required
to cause 30% lysis of 5 x 103 target cells. In some experiments,
retargeting mAbs (anti-Leu-4 or 3G8) were added to a final con-
centration of 0.5 pg/ml.
ImmunocytochemicalStaining.
￿
A rat anti-mouse PFP mAb, PI-8
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￿
Cytotoxic Activity of Freshly Isolated or IL-2-activated PB y/S T Cells
' LU was defined as the number of effector cells required to cause 30% lysis of 5 x 103 target cells .
t mAbs were added to 4-h s1Cr release assay at a final concentration of 0.5 wg/ml .
s Isolated lymphocytes were cultured with 100 U/ml of rIL-2 for 18 h .
(6), strongly crossreacts with human PFP (manuscript in prepara-
tion) . Immunocytochemical staining of isolated human lympho-
cyte subsets with P1-8 wasperformed as described for murine lym-
phocytes (6) .
RNA Analysis.
￿
Preparation of total cellular RNA, Northern
blot analysis with "P-labeled human PFP cDNA (7) and murine
18SribosomalRNAcDNA (Dr. L. Varesio, Frederick Cancer-Re-
search Facility, Frederick, MD) probes, and relative quantification
of PFP mRNA were performed as described previously (8) .
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Results and Discussion
Cytotoxic Activity ofFreshly Isolated or IL2-activatedPB y/6
T Cells. We first tested the cytotoxic activity offreshly iso-
lated y/b T cellsfromPBL or thymocytes using three criteria
(Table 1) . ANKsensitive human target K562 was used for
evaluating NK cytotoxicity. A NK-resistant murine target
P815 bearing FcyR was used for evaluating LAK cytotox-
icity and the cytolytic potential redirected by anti-CD3mAb .
Figure 1.
￿
Immunocytochemical staining of PB y/ST cells (A), PB NK cells (B), PBCD8* T cells (C, and 'y/S thymocytes (D) with an anti-PFP
mAb (x 200) .
Expression of Pore-forming Protein in Human Peripheral Blood y/ST Cells
Exp . Effector cells K562
LU`/106 Cells
P815
Leu-4t 3G8t
1 Fresh NK cells 44 .4 <0.1 ND 37.0
IL-2-activateds NK cells 70.2 11.2 ND 40.0
Fresh CD8' T cells <0 .1 <0.1 7.1 ND
IL-2 activated CD8' T cells <0.1 <0.1 28.6 ND
Fresh y/S T cells 32.2 <0.1 20.0 ND
IL-2-activated y/S T cells 51.2 6.1 46.6 ND
2 Fresh y/S T cells 27.0 <0.1 33.4 ND
IL-2-activated y/S T cells 55.6 10.6 64.6 ND
3 Fresh y/S T cells 25.6 <0.1 35.8 ND
IL-2-activated y/S T cells 52.6 9.0 64.6 ND
4 Fresh y/S thymocytes <0.1 <0.1 <0.1 NDFreshly isolatedPB y/6 T cells from all three donors exhibited
substantial NK cytotoxicity but no LAK cytotoxicity. The
possibility that the cytotoxicity against K562 resulted from
retargeting by theTCR6-1 mAb used and the FcIR on K562
could be eliminated because the same positively sorted y/6
T cells did not lyse FcyR+ P815 target cells. In addition,
freshly isolated y/b T cells had a greater cytolytic potential
than CD8+ T cells when triggered by anti-CD3 mAb, and
their cytotoxic potential was sometimes comparable with that
of freshly isolated NK cells triggered by anti-CD16 mAb.
These results clearly indicate that PB y/6 T cells have a po-
tent cytotoxic activity comparable withPBNK cells in vivo.
In contrast, y/6 T cells in the thymus (y/6 thymocytes) had
neither NK activity nor cytolytic potential, suggesting that
y/6T cells acquire cytotoxic activity post- or extra-thymically.
We next examined the IL2 induction of cytotoxic activity
ofPB y/6 T cells. In a previous study, we demonstrated that
NK and LAK cytotoxicity, but not the cytolytic potential
ofPB NK cells, were upregulated by a briefexposure to IL2,
while, in contrast, CD8+ T cells developed a high cytolytic
potential, but not NK or LAK cytotoxicity by the same treat-
ment (5) . Similar results were obtained again herein with
NK and CD8+ T cells as controls (Table 1) . NK cytotox-
icity and cytolytic potential ofPB y/6T cells were augmented
by a brief exposure to IL2 by about twofold. In addition,
PB y/6 T cells exhibited LAK cytotoxicity after IL2 stimu-
lation like NK cells .
Constitutive Expression ofPFP in PB y/6 T Cells.
￿
To fur-
ther define the cytolytic function ofPB y/6 T cells, we ex-
amined the expression of PFP, which has been proposed to
be a potent mediator of cell-mediated cytolysis (4), in these
cellsby immunocytochemical staining with an anti-PFPmAb
and Northern blot analysis. Previously, we demonstrated a
Figure 2.
￿
Expression of PFP mRNA in PBL subsets. CD3 -56+ NK
cells, ti/6+ T cells, and -y/6-CD8* T cells were cultured for 6 h in the
presence (+) or absence (-) o£ rlI.2 (1,000 U/ml) . Total cellular RNA
was isolated from the cultured cells, and Northern blot analysis was per-
formed on 1-3 ugofRNA . The filter was hybridized with acDNA probe
for human PFP, then stripped by washing with boiling0.01x SSC/0.01%
SDS, and rehybridized with a cDNA probe for murine 18S RNA .
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strong correlation between cytolytic potential andPFPmRNA
expression in CD8+ T and NK cells (5) .
Immunocytochemical staining with an anti-PFP mAb re-
vealed a dispersely granular pattern of cytoplasmic staining
in 95-100% of the freshly isolated y/6 T cells (Fig . 1 A),
95-100% ofCD3-56+ NK cells (Fig . 1 B), and 13-30% of
CD8+ T cells (Fig. 1 C) among eight individuals . Consis-
tent with previous observations (9, 10), the granular mor-
phology ofy/6T cells was also observed under electron mi-
croscopy, demonstrating that the majority of the cells had
electron-dense granules scattered in the cytoplasm (data not
shown) . In contrast, y/6 thymocytes exhibited virtually no
staining (Fig. 1 D). These results indicate that y/6 T cells,
like NK cells, in PB had abundant PFP in their cytoplasmic
granules, but those in the thymus did not, thereby suggesting
that the cytolytic machinery involving PFP develops post-
or extra-thymically.
Constitutive expression of PFP in y/6 T cells was also
demonstrated by Northern blot analysis (Fig . 2) . PB y/6 T
cells expressed abundant PFP mRNA without IL-2 stimula-
tion at about halfthe level ofPB NK cells and N20-fold more
than CD8+ T cells (Table 2) . A brief exposure to IL2 led
to a striking induction (N13-fold) of PFP gene expression
in CD8+ T cells but not significantly in y/6 T cells or NK
cells (Fig. 2, Table 2) . These results indicate that PB 'Y/6 T
cells constitutively express PFP.
We recently reported that abnormally expanded PB y/6
T cells, which were prepared from a granular lymphocyte
proliferative disorder (GLPD) patient, exhibited strong NK
activity and constitutively expressed PFP mRNA (11) . The
present results indicate that this previous observation did not
represent a special case ofGLPD but a common feature of
normal PB y/6 T cells .
It has been demonstrated that human PB y/6 T cells are
mainly composed of two mutually exclusive subsets distin-
guished by their reactivity with antiTCR-y/6 mAbs, 13133,
Table 2 .
￿
Induction ofPFP mRNA Expression in Lymphocyte
Subsets by Brief Exposure to IL-2
' Isolated lymphocyte subsets were cultured with or without 1,000U/ml
of rIL-2 for 6 h .
t Expression of PFP mRNA relative to untreated CD8+ T cells equal
to unity was determined by quantitative densitometry of Northern blots
indicated in Fig. 2 (ratio of PFP/18S RNA expression) .
Subset Treatment"
Relative PFP
mRNA expression$
NK cells - 38.8
IL-2 34.1
CD8' T cells - 1 .0
IL-2 12.9
y/6 T cells - 19.9
IL-2 23.0and 6TCS-1(12). These two subsets exhibiteddifferential tissue
distribution (13), and thecell linesestablished from thesetwo
subsets exhibited differential morphology (14) and capacity
to spontaneouslylyse tumor target cells(12). However, since
virtually all PB y/S T cells containing 4-22% 6T'CS-1+ cells
(among eight individuals) were granularly stainedwith anti-
PFP mAb, there appears to be no difference in PFP expres-
sion between these two subsets.
Studieson the distribution of y/S T cells in murine tissues
suggestedthat theseTcells may exert their functions prefer-
entially at themucosal level (15) . Freshly isolated murine in-
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